Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

15.360
-0.140-0.90%
Volume:3.14M
Turnover:48.24M
Market Cap:47.94B
PE:5.74
High:15.500
Open:15.470
Low:15.260
Close:15.500
52wk High:21.258
52wk Low:15.187
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:0.54
T/O Rate:0.23%
Dividend:0.79
Dividend Rate:5.14%
EPS(LYR):2.678
ROE:8.04%
ROA:2.56%
PB:0.48
PE(LYR):5.74
PS:0.07

Loading ...

SINOPHARM Receives Additional Investment from Lazard Asset Management LLC Involving 2.1 Million Shares

Deep News
·
Mar 30

A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement

Simply Wall St.
·
Mar 28

SINOPHARM Establishes New Subsidiary in Xiong'an

Deep News
·
Mar 28

Lazard Asset Management Increases Stake in SINOPHARM by Approximately 2.1 Million Shares

Stock News
·
Mar 27

Sinopharm Group Stock Falls 3.6% in Hong Kong

Dow Jones
·
Mar 24

UBS Slightly Raises SINOPHARM (01099) Target Price to HK$25.7, Anticipates Stronger Revenue Growth This Year

Stock News
·
Mar 24

SINOPHARM Shares Drop Nearly 5% Following Annual Results; Citi Trims Target Price

Stock News
·
Mar 24

Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million

Reuters
·
Mar 23

SINOPHARM Reports Annual Earnings with 1.5% Rise in Net Profit Attributable to Owners

Stock News
·
Mar 23

BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN

Reuters
·
Mar 23

Sinopharm Group proposes final dividend of RMB 0.69 per share

Reuters
·
Mar 23

Sinopharm Group - FY Profit Attributable RMB7.16 Bln

THOMSON REUTERS
·
Mar 23

Sinopharm Group - Final Dividend of RMB0.69 per Ordinary Share Is to Be Proposed

THOMSON REUTERS
·
Mar 23

Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention

Simply Wall St.
·
Mar 20

SINOPHARM Subsidiary Reports Annual Operating Profit of RMB 1.25 Billion, Up 2.38%

Stock News
·
Mar 19

Sinopharm subsidiary CNMDC posts RMB 74.89 billion 2025 revenue and RMB 506.76 million comprehensive income attributable to parent owners

Reuters
·
Mar 19

OSR subsidiary Woori IO signs NDA with Sinopharm to explore China opportunities

Reuters
·
Mar 19

Sinopharm Group (01099.HK): Subsidiary Sinopharm Accord Posts 76.8% Surge in 2025 Net Profit Despite 1.29% Dip in Revenue

Bulletin Express
·
Mar 18

Sinopharm Accord net profit rises 76.8% to RMB1.14 billion in 2025

Reuters
·
Mar 18

Sinopharm Group FY Revenue RMB 73,416 Million

THOMSON REUTERS
·
Mar 18